2nd Quarter - Report

VENN STRATEGIES for TRINETX

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policy issues impacting the use of real-world data in clinical trials.

LobbyistCovered position, as disclosed
NATASCHA CUMBERLIDGE —
BROOKS KEEFER New Policy Analyst-Congressional Joint Economic Committee (JEC),Republicans, Legislative Assistant-Congressman Pat Tiberi (R-OH-12)
MICHELLE SEGER —
STEPHANIE SILVERMAN —
MICHAEL SPIRA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.